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WHAT THIS PAPER ADDS
 Transcutaneous oximetry (TcPO2) has been proposed as amethod to predict healing complications of lower limb amputations and to
select appropriate amputation levels. This systematic review and meta-analysis presents the current state of the literature on this
topic and pools the relevant observational study results in a meta-analysis. This analysis suggests that TcPO2 predicts healing
complications of lower limb amputations, but its independent predictive value has not been determined. The use of TcPO2 may
provide surgeons with an important tool for assessing patients for lower limb amputation and for making clinical decisions
regarding an appropriate level of amputation.a r t i c l e i n f o
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Objective: To determine the validity of transcutaneous oximetry (TcPO2) as a predictor of lower limb
amputation healing complications.
Design: A systematic review and meta-analysis.
Methods: We searched ﬁve major medical databases, relevant review articles and reference lists and
included all studies that evaluated TcPO2 for its ability to predict lower limb amputation healing failure.
We selected eligible articles and conducted data abstraction independently and in duplicate.
Results: Thirty-one studies, enrolling 1824 patients with 1960 amputations, met our inclusion criteria. Only
one study reported undertaking a multivariable analysis, which demonstrated that a TcPO2 level below
20 mmHg was an independent predictor of re-amputation occurrence (adjusted odds ratio (OR) 3.08, 95%
conﬁdence interval (CI) 1.19e7.98). Fourteen prospective cohort studies reported data that allowed for the
calculation of an unadjusted relative risk of lower limb amputation healing complications leading to
amputation revision associated with a TcPO2 level below cut-offs of 10 mmHg (1.80; 95% CI 1.19e2.72),
20mmHg (1.75; 95%CI 1.27e2.40) 30mmHg (1.41; 95%CI 1.22e1.62) and40mmHg (1.24; 95%CI 1.13e1.39).
Conclusions: This review suggests that TcPO2 predicts healing complications of lower limb amputations. A
value of less than 40 mmHg results in a 24% increased risk of healing complication compared to over
40 mmHg and the risk further increases as the TcPO2 decreases. There is, however, insufﬁcient evidence
to judge whether this tool adds important information beyond clinical data or to suggest an optimal
threshold value. There is a need for a large, sufﬁciently powered study that adjusts for appropriate
clinical variables.
 2011 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Cardiac, Vascular and Stroke
st, Hamilton, ON, Canada L8L
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ciety for Vascular Surgery. PublisheThe incidence of major lower limb amputations, including
below-knee amputation (BKA) and above-knee amputation (AKA),
has most recently been reported at 5.1 for every 100,000 people in
England.1 Other studies2 have cited a much higher rate in North
America, especially among Native populations. Feinglass et al.3
estimated a rate of 25 amputations per 100,000 people in theird by Elsevier Ltd. All rights reserved.
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Survey. If one considers that approximately 82% of these amputa-
tions are a result of vascular complications4 and that the rate of
diabetes is increasing, the number of amputations is expected to
increase substantially in the future.
Within the last two decades, there has been a trend towards
more distal lower limb amputations. Most recent studies report
a BKA:AKA ratio of approximately 2:1.5e8 This movement has been
fuelled by evidence that BKAs improve patients’ rehabilitation,9
mobility,10 independence, functional capabilities11 and quality of
life.12 Furthermore, short- and mid-term mortality rates differ
signiﬁcantly between the two procedures: 30-day mortality rates
are reported to be between 3.6%13 and 10.0%14 for BKAs and
between 13.2%15 and 24.0%16 for AKAs. Ranges for 1-year mortality
rates are 4.3%17e25.5%5 and 24.4%17e49.4%5 for BKAs and AKAs,
respectively. Although there is a trend towards more distal lower
limb amputations and recent evidence supports the advantages
of BKA over AKA, there is still an appropriate hesitancy to adopt BKA
for all patients. Failure of the surgical stump to heal postoperatively
is more common in BKAs.7,18 This failure of primary healing often
results in the need for revision of the amputation to a more prox-
imal level. Revision of BKA to AKA is required in approximately
14.8% of cases5,6,16,19 but has been reported at a rate as high as
42.0%.20 This outcome is associated with not only the decreased
ability for rehabilitation and quality of life found in all AKAs, but
also the risks of undergoing a second surgery, including general
anaesthesia, blood loss, infection and cardiovascular complications.
Current methods to select the level of amputation in patients
with critical and chronic ischaemia at many vascular surgery
centres are largely clinically based21 including pallor, erythema,
temperature, pulses and the presence of necrosis. Adoption of more
specialised measurements for this decision-making process varies
by country and is centre-speciﬁc. Numerous studies have evaluated
these measurements for their predictive value in selecting a more
appropriate level of amputation:12 ankleebrachial pressure index,
segmental blood pressures, arteriography,22 skin blood ﬂow, skin
perfusion pressure, laser Doppler ﬂowmetry and thermography.
Despite these measures, physicians’ abilities to predict surgical
wound healing remain suboptimal.
Transcutaneous oximetry (TcPO2), a non-invasive method to
analyse the partial pressure of oxygen (PO2) in tissue, has been
proposed as a method to select lower limb amputation levels. This
technique uses a sensor containing Clark polarographic electrodes
that is placed on the skin at the area of interest, avoiding callous
areas, oedema and bony prominences. The sensor warms the
surrounding skin, causing localised hyperaemia and facilitating
oxygen diffusion. The measured PO2 in the dermis is displayed in
millimetres of mercury, with a normal healthy value in the foot
being >50 mmHg.23 A value of <40 mmHg is thought to represent
sufﬁcient hypoxia to impair wound healing.23 A cut-off point below
which the likelihood of healing complications of amputation
stumps is increased is, however, poorly deﬁned.12 The determina-
tion of this cut-off may assist in clinical decision making, as well as
guide future research to improve outcomes.
We conducted a systematic review of the medical literature to
determine the value of TcPO2 as a predictor of healing complica-
tions of lower limb amputation.
Methods
We have followed the Meta-analysis of Observational Studies in
Epidemiology (MOOSE) and Preferred Reporting Items for
Systematic Reviews and Meta-Analyses (PRISMA) statement
guidelines in the design, conduct and reporting of this systematic
review and meta-analysis.Search strategy
Electronic searches were conducted of the following databases:
the Cochrane Library, CINAHL, EMBASE, MEDLINE and Web of
Science, using keyword and subject heading searches of terms such
as ‘amputation’ and ‘transcutaneous oximetry’. The searches were
conducted from the start date of each source to October 2011. The
speciﬁc search strategy methods for each database are outlined in
the Supplementary Data Section (online only). Reference lists of
articles that met the eligibility criteria and relevant review articles
were hand-searched for additional articles.
Study eligibility
All studies evaluating healing of lower limb amputations for
vascular complications in adult patients (age  18 years) were
included if they fulﬁlled the following criteria: conducted at least
one preoperative TcPO2 measurement at the site of the planned
amputation; reported the postoperative healing status of the
surgical wound or rate of amputation revision to a more proximal
level; and provided data to assess TcPO2 measurements as
a predictor of amputation healing.
Study eligibility was assessed in two stages. First, two individuals
independently screened the titles and abstracts of each citation
identiﬁed in our search. All articles identiﬁed as having any possi-
bility of fulﬁlling our eligibility criteria in the screening process were
retrieved toundergo full textevaluation. Two independent reviewers
evaluated each full text article selected during the screening stage. In
cases of disagreement, the reviewers discussed the reasoning for
their decisions and came to a consensus. If disagreements were not
resolved during this process, an independent third adjudicator
assessed the paper in question and made a ﬁnal decision. Non-
English studies were assessed by third-party translators.
Data collection
Two independent reviewers abstracted the following descrip-
tive data from eligible studies: year of publication, sample size,
patient characteristics, length of follow-up, type of amputation,
method of amputation level selection, TcPO2 measurements,
method of assessment of amputation stump healing and the deﬁ-
nition of a non-healing event. Event rates in groups of patients
above and below TcPO2 cut-off levels of 10, 20, 30 and 40 mmHg
were collected from individual studies where available. Data were
abstracted regarding independent associations between TcPO2 and
amputation stump healing in studies that undertook multivariable
analysis, propensity analysis or matched cases and controls. If
a study stated that a type of multivariable analysiswas used, but the
speciﬁc results for a cut-off TcPO2 level were not reported, the
authors were contacted for the data.
Study quality assessment
The following indicators of study validity were collected: the
method of sample selection, the number of patients lost to follow-
up, whether there was blinding of data collectors and outcome
assessors to the TcPO2 measurements and whether the assessment
method for amputation stump healing was objective and
standardised.
Statistical analysis
There were an insufﬁcient number of studies reporting multi-
variable analysis to perform a meta-analysis and pool the summary
estimates of TcPO2 as an independent predictor of amputation
Figure 1. PRISMA ﬂow diagram.
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calculated for each study at each cut-off level. The unadjusted RRs
were pooled using the DerSimonian and Laird random-effects
model24 based on the ManteleHaenszel estimate. This analysis was
done using Review Manager (RevMan) Version 5.1 (Copenhagen:
The Nordic Cochrane Centre, The Cochrane Collaboration, 2011).
To assess heterogeneity, an I2 value was calculated. Substantial
heterogeneity was deﬁned as an I2 of 50%. We originally planned
to pool the data from all of the studies found in our review. Due to
the substantial heterogeneity found, this analysis was deemed
inappropriate. Sensitivity analyses demonstrated that much of this
heterogeneity was due to variability in study design and outcome
deﬁnition. Therefore, we pooled only the prospective cohort
studies that used the most objective outcome deﬁnition: occur-
rence of amputation revision.
A random-effects meta-regression of the log RR was used to
assess the plausible explanatory variables of TcPO2 cut-off value,
year of publication and length of patient follow-up. It was
hypothesised that decreasing the cut-off value would result in
a signiﬁcantly stronger association of TcPO2 levels below a cut-off
with healing failure. It was thought that more recent publications
might demonstrate signiﬁcantly higher summary estimates above
1.00 due to advancements in TcPO2 technology that led to improved
measurement accuracy. Finally, increased length of follow-up
might capture more events and lead to a weaker association of
TcPO2 levels below a cut-off with healing failure. We further
explored the type of amputation conducted for its effect on
heterogeneity using sensitivity analyses. For each cut-off, we
compared the pooled summary estimate of prospective cohort
studies that reported the occurrence of amputation revision with
the estimate derived from an analysis of only those studies that
evaluated patients with BKA or AKA. Differences were assessed
using the c2 test with a p-value of 0.05 being considered signiﬁcant.
Results
Description of studies
Of the 992 articles identiﬁed in the literature search, 31 met the
inclusion criteria.25e55 A summary of the study selection can be
found in Fig. 1. Only one of these articles42 undertook a multivari-
able analysis to assess TcPO2 as an independent predictor.
The 31 studies thatmet the inclusion criteria for this reviewwere
of various designs and focussed on slightly different research ques-
tions. Table 1 summarises the general characteristics of these studies.
Of the 26 observational studies, 21 were prospective cohort studies
while ﬁve were retrospective chart reviews. The remaining ﬁve
studies,29,30,39,42,49 were designed as clinical trials, assessing the use
of TcPO2 as amethod for selecting lower limbamputation levels,with
one exception; Butler et al.29 focussed on the role of supplemental
oxygen therapy in lower limb amputation healing with secondary
analyses that addressed our review question. Only patients from the
control group of this trial were included in our review.
In the 31 studies included in this review, a total of 1824 patients
with 1960 amputations were evaluated with TcPO2. Indications for
lower limb amputation were largely similar across all the studies
and included: peripheral vascular disease, occlusive arterial
disease, non-healing ischaemic ulcers, infection, gangrene and rest
pain. Only one study55 focussed solely on patients with diabetes
mellitus.
Study quality assessment
A summary of the study quality assessment can be found in
Table 2. The majority of the studies included in this review were ofsingle-centre observational design and approached all patients
reporting to the centre with non-healing ulcers, severe leg
ischaemia or those that were scheduled for lower limb amputa-
tions. Only two of the studies further described exclusion criteria
that would minimise the effect of confounders such as ipsilateral
knee joint disease in BKAs29 or other handicaps.31 Two patients in
the study by Andrews et al.26 were lost to follow-up. None of the
other studies reported any patients lost to follow-up.
Only six studies27,30,35,41,47,50 stated speciﬁcally that they blin-
ded the surgeons who selected the amputation level to the results
of the TcPO2 measurements. No studies reported blinding of the
outcome assessor. However, as many of the studies considered re-
amputation their end point, this is unlikely to have been a signiﬁ-
cant source of bias.
A major concern in the 10 studies that did not use re-
amputation as the end point was the lack of objectivity in their
deﬁnition of their primary outcome. Only two of these studies40,55
clearly deﬁned how healing was assessed.Study results
Keyzer-Dekker et al.42 was the only study to analyse TcPO2 as an
independent predictor of amputation stump healing failure using
multivariable analysis. They deﬁned their end point as occurrence
of re-amputation during a 1-year follow-upwhich occurred in 15 of
the 52 participants (28.8%). The multivariable analysis adjusted for
the type of amputation, the presence of gangrene, phantom or rest
pain, acute ischaemia, vascular disease and diabetes mellitus. An
adjusted odds ratio for the association between a preoperative
TcPO2 level below 20 mmHg and occurrence of re-amputation was
calculated to be 3.08 (95% conﬁdence interval (CI) 1.19e7.98;
p ¼ 0.021).
Two studies49,54 only communicated their results descriptively.
In each of these, the authors suggested that there was a correlation
between low TcPO2 values and amputation stump healing
complication. These authors were contacted to provide further
clariﬁcation or data. Wyss et al.54 responded that the primary data
were no longer available. Two studies25,39 performed lower limb
amputations at the level where TcPO2 was 24 or 30 mmHg,
respectively. Healing failure occurred in 3 of 38 (7.9%) of amputa-
tions in Ameli et al.25 and 2 of 20 (10.0%) amputations in Ito et al.39
Nineteen of the studies in this review, representing 1212
patients with 1280 amputations, reported the results of a
Table 1
Description of studies included in review.
Study Design Sample size Endpoint outcome Events (%) p-valuea
Ameli, 1989 Clinical trial 38 Primary healing failure (not deﬁned) 3 (7.9) e
Andrews, 2010 Restrospective
cohort/chart review
371 Amputation revision to a more proximal level 95 (25.5) <0.05
Bacharach, 1992 Retrospective
cohort/chart review
75 (90 amputations) Amputation revision to a more proximal level 21 (23.3) <0.001
Bunt, 1996 Prospective cohort 103 (133 amputations) Healing failure (not deﬁned) 27 (20.3) <0.05
Burgess, 1982 Prospective cohort 37 Amputation revision 7 (18.9) <0.01
Butler, 1987 Clinical trial 22 Amputation revision 10 (25.6) <0.005
Casillas, 1993 Retrospective
cohort/chart review
43 (46 amputations) Prosthetic ﬁtting score, Amputation revision
to a more proximal level
4 (8.7) e
Chambon, 1992 Prospective cohort 33 (36 amputations) Healing failure (not deﬁned) 10 (27.8) 0.05
Christensen, 1986 Prospective cohort 42 Amputation revision 5 (11.9) <0.002
Depairon, 1986 Prospective cohort 34 (35 amputations) Amputation revision 5 (14.3) e
Dowd, 1986 Prospective cohort 51 Healing failure (not deﬁned) 9 (17.6) e
Falstie-Jense, 1989 Retrospective
cohort/chart review
72 (74 amputations) Healing failure (not deﬁned) 15 (20.3) NS
Harward, 1985 Prospective cohort 101 (119 amputations) Amputation revision 20 (16.8) e
Hauser, 1987 Prospective cohort 66 Healing failure (not deﬁned) 21 (31.8) <0.001
Ito, 1984 Clinical trial 29 (31 amputations) Healing failure (not deﬁned) 3 (9.7) e
Karanﬁlian, 1986 Prospective cohort 20 Open or nonviable wound edges; Signs of infection 2 (10.0) <0.05
Katsamouris, 1984 Prospective cohort 29 Necrosis or breakdown of the initial amputation site
without evidence of secondary healing, requiring
amputation revision to higher level
5 (17.2) Anterior
measurement: <0.02
Posterior
measurement: <0.0001
Keyzer-Dekker, 2006 Clinical trial 52 Amputation revision to a more proximal level 15 (28.8) e
Kram, 1989 Prospective cohort 40 Amputation revision to a more proximal level 7 (17.5) <0.01
Misuri, 2000 Prospective cohort 20 (30 amputations) Amputation revision 13 (43.3) 0.0004
Mustapha, 1983 Prospective cohort 14 Healing failure (not deﬁned) 5 (35.7) <0.001
Pinzur, 1992 Prospective cohort 38 Amputation revision to a more proximal level 6 (15.8) e
Poredos, 2005 Prospective cohort 56 Amputation revision to a more proximal level 17 (30.4) <0.01
Ratliff, 1984 Prospective cohort 59 (62 amputations) Need for further surgical procedure, including
amputation revision to a more proximal level
15 (24.2) Above-knee
measurement: <0.001
Below-knee
measurement: <0.02
Rhodes, 1985 Clinical trial 12 Amputation revision to a more proximal level 1 (8.3) e
Slagsvold, 1989 Prospective cohort 25 Amputation revision to a more proximal level 3 (12.0) e
Szala, 1988 Prospective cohort 27 Amputation revision 7 (25.9) e
Wagner, 1988 Prospective cohort 109 (66 BKAs) Amputation revision or signiﬁcant debridement 13 (12.6) AKA with thigh
measurement: >0.05
AKA with calf
measurement: >0.05
BKA with thigh
measurement: 0.035
BKA with calf
measurement: <0.001
White, 1982 Prospective cohort 9 Amputation revision 3 (33.3) <0.01
Wyss, 1988 Prospective cohort 162 (206 amputations) Amputation revision 35 (17.0) e
Zgonis, 2005 Retrospective
cohort/chart review
35 (40 amputations) Presence of ulcer at the site of amputation
or amputation revision
12 (30.0) <0.01
a For difference between mean TcPO2 level of patients with events and those without using univariable analysis.
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Whitney U test. Eighteen studies26e30,32,33,38,40,41,43e45,47,48,52,53,55
demonstrated a signiﬁcant difference between the mean TcPO2
levels of the healed and non-healed groups, as deﬁned by a p-value
of less than 0.05. Only one study36 showed no signiﬁcant difference.
The remaining seven studies31,34,35,37,46,50,51 did not report
a univariable association between TcPO2 levels and lower limb
amputation healing complications, but presented data that allowed
for the calculation of an unadjusted RR of lower limb amputation
healing complication associated with a TcPO2 level below a cut-off
of 10, 20, 30 or 40 mmHg.
Meta-analysis
A total of 23 studies26e31,33e37,40e44,46e48,50e53 presented data
that allowed for the calculation of an unadjusted RR of lower limb
amputation healing complication associated with a TcPO2 level
below a cut-off of 10, 20, 30 or 40 mmHg. It was originally planned
to pool the results of all of these studies; however, due tosubstantial heterogeneity, this analysis was deemed inappropriate.
Instead, a meta-analysis was undertaken on the 14 prospective
cohort studies that reported the occurrence of amputation revi-
sion.28,33,34,37,41,43,44,46e48,50e53 These studies included 626 patients
with 658 amputations. Forest plots displaying the results of the
pooled analysis for each cut-off value are displayed in Figs. 2e5.
Based on 11 studies, a TcPO2 value less than 10mmHg displayed the
strongest association with healing complication (RR 1.80, 95% CI
1.19e2.72). The 20-mmHg subgroup included all 14 of the studies
and resulted in a pooled RR of 1.75 (95% CI 1.27e2.40). Cut-offs of
30 mmHg and 40 mmHg displayed pooled RRs of 1.41 (95% CI
1.22e1.62) and 1.24 (95% CI 1.13e1.39), respectively. The pooled RRs
for all four subgroups were statistically signiﬁcant.
Heterogeneity
Substantial heterogeneity was observed in the 20-mmHg cut-off
analysis (I2 ¼ 68%). Heterogeneity in the 10, 30 and 40 mmHg
accounted for 47%, 44% and 22% of the variation between studies,
Table 2
Study quality assessment.
Study Method of sample selection Number of patients
lost to follow-up
Blinding Standardization of healing
assessment method
Ameli, 1989 Consecutive patients None reported No blinding reported No
Andrews, 2010 Retrospective selection from a surgical database Two No blinding reported Yes
Bacharach, 1992 Retrospective selection from patient records None reported Surgeons blinded Yes
Bunt, 1996 Consecutive patients None reported Surgeons blinded No
Burgess, 1982 Consecutive patients None reported No blinding reported Yes
Butler, 1987 Consecutive patients, controlling for
ipsilateral knee joint disease
None reported No blinding reported Yes
Casillas, 1993 Retrospective selection from patient records,
controlling for ambulatory handicaps
None reported No blinding reported Yes
Chambon, 1992 Consecutive patients None reported No blinding reported No
Christensen, 1986 Consecutive patients None reported No blinding reported Yes
Depairon, 1986 Consecutive patients None reported No blinding reported Yes
Dowd, 1986 Consecutive patients None reported Surgeons blinded No
Falstie-Jense, 1989 Retrospective selection from patient records None reported No blinding reported No
Harward, 1985 Consecutive patients None reported No blinding reported Yes
Hauser, 1987 Consecutive patients None reported No blinding reported No
Ito, 1984 Consecutive patients None reported No blinding reported No
Karanﬁlian, 1986 Consecutive patients None reported No blinding reported Yes
Katsamouris, 1984 Consecutive patients None reported Surgeons blinded Yes
Keyzer-Dekker, 2006 Consecutive patients None reported No blinding reported Yes
Kram, 1989 Consecutive patients None reported No blinding reported Yes
Misuri, 2000 Consecutive patients None reported No blinding reported Yes
Mustapha, 1983 Consecutive patients None reported No blinding reported No
Pinzur, 1992 Consecutive patients None reported No blinding reported Yes
Poredos, 2005 Consecutive patients None reported Surgeons blinded Yes
Ratliff, 1984 Consecutive patients None reported No blinding reported Yes
Rhodes, 1985 Consecutive patients None reported No blinding reported Yes
Slagsvold, 1989 Consecutive patients None reported Surgeons blinded Yes
Szala, 1988 Consecutive patients None reported No blinding reported Yes
Wagner, 1988 Consecutive patients None reported No blinding reported Yes
White, 1982 Consecutive patients None reported No blinding reported Yes
Wyss, 1988 Consecutive patients None reported No blinding reported Yes
Zgonis, 2005 Retrospective selection from patient records None reported No blinding reported Yes
K.A. Arsenault et al. / European Journal of Vascular and Endovascular Surgery 43 (2012) 329e336 333respectively. There were statistically signiﬁcant differences
between the effect estimates at a cut-off of 20 mmHg when
compared to 40 mmHg (p ¼ 0.04) and borderline statistically
signiﬁcant differences between the effect estimates at 10 mmHg
and 40mmHg (p¼ 0.08), but not when comparing the other cut-off
values. In the meta-regression analysis, neither year of publication
nor length of follow-up explained the heterogeneity found.
Sensitivity analyses using only prospective cohort studies
that evaluated BKAs and AKAs and that deﬁned their end point
outcome as the occurrence of amputation revision for each cut-off
value demonstrated a reduction in the proportion of variation
explained by heterogeneity between studies (Table 3). TheseFigure 2. Forest plot of unadjusted risk of lower limb amputation healinanalyses were associated with pooled RRs further from 1.00 for all
of the cut-off values, though these differences were not statistically
signiﬁcant.
Discussion
Clinical implications
The studies summarised in this review suggest an association
between low TcPO2 values and healing failure of the lower limb
amputation stump. Pooling of unadjusted summary estimates from
14 prospective cohort studies demonstrated a signiﬁcantg failure associated with preoperative TcPO2 level below 10 mmHg.
Figure 3. Forest plot of unadjusted risk of lower limb amputation healing failure associated with preoperative TcPO2 level below 20 mmHg.
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leading to amputation revision and a TcPO2 level below cut-offs of
10e40 mmHg. The RR of lower limb amputation healing failure for
patients with a TcPO2 value below a cut-off appears to decrease
with increasing cut-off values. This inverse relationship supports
a graded effect of evaluated cut-off values on risk and is in the
direction we hypothesised.
The use of TcPO2 in addition to the clinical examination in
determining an appropriate level for amputation selection may be
warranted, but its independent predictive value has not been
determined. Furthermore, a cut-off value below which healing
failure is likely has not been optimally deﬁned. Nevertheless, TcPO2
is a promising tool and its adoption may signiﬁcantly assist in the
surgical and clinical care of this patient population by providing
clinicians with a means to assess appropriate lower limb amputa-
tion levels. This will hopefully prevent amputations at inappro-
priate levels and thus subsequent amputation revisions, as well as
possibly identifying patients who will heal at a more distal level.
More distal amputations have been shown to be associated with
reduced mortality and improved quality of life e this is an impor-
tant clinical goal.Figure 4. Forest plot of unadjusted risk of lower limb amputation healingLimitations
This review was limited by the low number of studies reporting
a multivariable association between TcPO2 levels and amputation
stump healing complications. Despite using a sensitive search
strategy without language restrictions in ﬁve relevant electronic
databases and hand-searches of reference lists and relative reviews,
only one such study was retrieved. Without further research, the
independent predictive ability of TcPO2, and thus its usefulness in
clinical practice, cannot be properly assessed.
Our meta-regression demonstrated that TcPO2 cut-off values,
year of publication and length of follow-up could not explain all of
the heterogeneity in this analysis. Despite controlling for vari-
ability in study design and methods of assessing healing of the
amputation stump, there was signiﬁcant heterogeneity in the
analysis of a 20-mmHg cut-off. A sensitivity analysis on the type of
amputation studied did lead to a reduction in heterogeneity in
each analysis. However, it did not result in a signiﬁcant change in
the pooled summary estimate for any cut-off value. Our a priori
hypothesis regarding heterogeneity also included variability in
study validity, patient characteristics and methods of measuringfailure associated with preoperative TcPO2 level below a 30 mmHg.
Figure 5. Forest plot of unadjusted risk of lower limb amputation healing failure associated with preoperative TcPO2 level below 40 mmHg.
Table 3
Sensitivity analyses.
Cut-off value
(mmHg)
Meta-analysis Sensitivity analysis p-valuea
10 RR 1.80
(95% CI 1.19e2.72)
I2 ¼ 47%
RR 3.29
(95% CI 1.64e6.61)
I2 ¼ 0%
0.15
20 RR 1.75
(95% CI 1.27e2.40)
I2 ¼ 68%
RR 2.01
(95% CI 1.41e2.44)
I2 ¼ 9%
0.56
30 RR 1.41
(95% CI 1.22e1.62)
I2 ¼ 44%
RR 1.53
(95% CI 1.31e1.79)
I2 ¼ 0%
0.44
40 RR 1.24
(95% CI 1.13e1.35)
I2 ¼ 22%
RR 1.26
(95% CI 1.14e1.39)
I2 ¼ 0%
0.77
a For difference between summary estimates with the studies pooled in themeta-
analysis and with the sensitivity analysis, assessed using the c2 test.
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studies to assess these variables in the meta-regression or sensi-
tivity analyses. These sources of heterogeneity must be evaluated
when considering applying the results of this meta-analysis to
individual patients.
Finally, the studies included in this review were generally small
and hadmethodological limitations including a lack of blinding and
subjective assessment of healing failure of the amputation stump
which may have introduced bias.
Conclusions
This review suggests that there is a positive and statistically
signiﬁcant association between TcPO2 values below a cut-off level
and healing complications of lower limb amputations. There is,
however, insufﬁcient evidence to judge whether this tool adds
important information to clinical examination. Furthermore, a cut-
off point at which this tool would perform optimally has not been
determined. A large, sufﬁciently powered study that uses multi-
variable analysis is needed to guide clinical practice and future
research.
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